Groundbreaking Development: Innovative mRNA Drug for Nasopharyngeal Cancer
Professor K.W. Lo and Professor Anna Tsang, together with some industry experts and collaborators, hosted a press conference organized by...
Follows our journey in developing the best therapeutics for patients with EBV-associated malignancies